Loading...
Please wait, while we are loading the content...
Similar Documents
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Roy, Louis |
| Copyright Year | 1989 |
| Abstract | Platelet activation may limit the response to tissue-type plasminogen activator (t-PA) during coronary thrombolysis in humans. As an index of platelet activation, we assessed thromboxane A2 biosynthesis during coronary thrombolysis with intravenous t-PA in patients with acute myocardial infarction. Urinary 2,3-dinor-thromboxane B2, a metabolite of thromboxane A2, was increased to a peak of 3,327 +/- 511 pg/mg creatinine (n = 12) following administration of intravenous t-PA and remained elevated for 48 hours. This increase was abolished by pretreatment with aspirin 325 mg orally (n = 6), indicating de novo biosynthesis of thromboxane A2 rather than washout of preformed metabolites during reperfusion. Prostacyclin (PGI2) biosynthesis, determined by excretion of 2,3-dinor-6-keto-PGF1 alpha, also increased after t-PA administration. However, this increase was less pronounced in patients who reperfused (28 +/- 3.3 ng.hr/mg creatinine) than in patients who failed to reperfuse (118 +/- 30 ng.hr/mg creatinine, p less than 0.05). These data provide evidence of platelet activation during coronary thrombolysis with t-PA. In patients who reperfuse, the reduction in PGI2 biosynthesis may be a marker of reperfusion injury to the vasculature and may further amplify platelet activation. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/80/6/1718.full.pdf |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/80/6/1718.full.pdf?download=true |
| PubMed reference number | 2513144v1 |
| Volume Number | 80 |
| Issue Number | 6 |
| Journal | Circulation |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Anabolism Aspirin Blood supply aspects Creatinine Epoprostenol Microgram per Kilogram Myocardial Infarction Oral cavity Patients Plasminogen Activator Platelet Activation Platelet Count measurement Reperfusion Injury Reperfusion Therapy Thrombolysis, function Thromboxane A2 Thromboxane B2 Thromboxanes alteplase |
| Content Type | Text |
| Resource Type | Article |